Bio Green Med Solution (BGMS) Cash & Current Investments (2010 - 2026)
Bio Green Med Solution (BGMS) posted quarterly Cash & Current Investments of $3.3 million for Q1 2026, down 4.35% year-over-year from $3.4 million in Q1 2025, and down 5.85% quarter-over-quarter from $3.5 million in Q4 2025.
Powered by 
Analysis
Bio Green Med Solution (BGMS) Cash & Current Investments (2010 - 2026) Analysis & Trends
Bio Green Med Solution (BGMS) has reported Cash & Current Investments for 17 consecutive years, with $3.3 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments fell 4.35% year-over-year to $3.3 million; the TTM figure through Mar 2026 stood at $3.3 million (down 4.35% YoY), while the FY2025 annual figure was $3.5 million, up 11.73% from the prior year.
- Cash & Current Investments declined to $3.3 million in Q1 2026 per BGMS's latest filing, from $3.5 million in the prior quarter.
- Across five years, Cash & Current Investments topped out at $29.6 million in Q1 2022 and bottomed at $75000.0 in Q4 2023.
- Historically, Cash & Current Investments has averaged $9.8 million across 5 years, with a median of $4.3 million in 2025.
- Annual changes were most pronounced in 2023 — Cash & Current Investments tumbled 99.67% — and 2024, when it soared 4082.67%.
- Bio Green Med Solution's Cash & Current Investments stood at $22.9 million in 2022, then sank by 99.67% to $75000.0 in 2023, then jumped by 4082.67% to $3.1 million in 2024, then gained by 11.73% to $3.5 million in 2025, then dropped by 5.85% to $3.3 million in 2026.
- Business Quant data shows BGMS's Cash & Current Investments at $3.3 million in Q1 2026, $3.5 million in Q4 2025, and $3.8 million in Q3 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 141.56 Bn | 133.71 Bn | 2.84 Bn | 7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 87.63 Bn | 79.64 Bn | 3.93 Bn | 7.99 Bn |
| 3 | Argenx Se | 64.65 Bn | 59.46 Bn | 1.37 Bn | 5.18 Bn |
| 4 | Moderna | 60.24 Bn | 55.10 Bn | 52.00 Mn | 5.14 Bn |
| 5 | Revolution Medicines | 44.13 Bn | 44.13 Bn | - | - |
| 6 | BeOne Medicines | 40.46 Bn | 35.36 Bn | 1.53 Bn | 5.10 Bn |
| 7 | Alnylam Pharmaceuticals | 35.86 Bn | 32.56 Bn | 992.69 Mn | 3.31 Bn |
| 8 | Royalty Pharma | 28.00 Bn | 27.16 Bn | - | 836.99 Mn |
| 9 | Insmed | 27.40 Bn | 26.24 Bn | 358.27 Mn | 1.16 Bn |
| 10 | Bio Green Med Solution | 4.68 Mn | 886,595.10 | 79,000.00 | 3.79 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 3.79 Mn |
| Mar 31, 2026 | 3.34 Mn |
| Dec 31, 2025 | 3.51 Mn |
| Sep 30, 2025 | 3.84 Mn |
| Jun 30, 2025 | 4.30 Mn |
| Mar 31, 2025 | 3.50 Mn |
| Dec 31, 2024 | 3.14 Mn |
| Sep 30, 2024 | 3.00 Mn |
| Jun 30, 2024 | 6.00 Mn |
| Mar 31, 2024 | 2.80 Mn |
| Dec 31, 2023 | 3.38 Mn |
| Sep 30, 2023 | 5.94 Mn |
| Jun 30, 2023 | 10.20 Mn |
| Mar 31, 2023 | 11.44 Mn |
| Dec 31, 2022 | 22.89 Mn |
| Sep 30, 2022 | 23.71 Mn |
| Jun 30, 2022 | 29.10 Mn |
| Mar 31, 2022 | 29.64 Mn |
| Dec 31, 2021 | 41.04 Mn |
| Sep 30, 2021 | 40.22 Mn |